What can $100 million in research and development do for shareholders? Well, it depends on the company.

Fisher & Paykel Healthcare shareholders look to be reaping the benefits as annual revenue pushed past $1 billion for and profit climbed 10 per cent to $209.2m.

The shares are up 240 per cent over the past five years and shareholders saw their annual dividend up 9 per cent at 23.25 cents.


Not bad on its own, but the company says there is more to come, tipping a profit of $240m to $250m for the current financial year.

Contrast that with another